Clinical features of early-onset high myopia in Chinese children: attention to comorbidities Authors: Yichao Ding, Feijia Xie, Jing Zhang, Mingming Jiang, Tong Wang, Xiaomei Wan Published: 2025 ABSTRACT AbstractBackgroundTo summarize the clinical features of early-onset high myopia (eoHM) in Chinese children.MethodsProspective observational study. Children with eoHM were enrolled in this study. After collecting a detailed medical history from the subjects, we comprehensively measured best-corrected visual acuity (BCVA), spherical equivalent (SE), and other ocular biological parameters. Whole-exome sequencing was performed on a portion of the probands with eoHM to identify potential pathogenic genes.ResultsA total of 232 children with early-onset myopia were included; among them, 122 (52.58%) had eoHM. The children with eoHM had a mean age of 4.2 ± 1.7 years, a mean BCVA of 0.65 ± 0.40 logMAR, a mean SE of -9.24 ± 3.48 D, a mean axial length (AL) of 24.94 ± 2.16 mm and a mean corneal curvature of 43.17 ± 2.00. Importantly, 59.02% (72/122) of the children with eoHM had other ocular or systemic diseases. The most common comorbidity of eoHM was lens dislocation (23/122, 18.85%), followed by inherited retinal degeneration (IRD) (14/122, 11.48%). Whole-exome sequencing was performed in 14 children with eoHM; hereditary eye disease-related genetic variants were found in all 14 children, and the variants in 92.86% (13/14) of the children were associated with the retina.ConclusionsThe results of this study indicate that over half of the children with eoHM are complicated by other ocular or systemic diseases, with lens and fundus disorders being the most common.Keywords: Early-onset high myopia, Children, Clinical features, Comorbidities, Gene Introduction High myopia (HM) is defined as a spherical refractive error exceeding − 6.00 spherical diopters (SD) or an axial length (AL) greater than 26 mm [1, 2]. In 2020, the prevalence of HM has been reported to be 5.1% in global populations [3]. In terms of regional distribution, the incidence of HM in Asian populations is much greater than that in non-Asian populations [4]. Both genetics and the environment play a role in HM [5, 6], and HM is associated with many serious eye complications, such as retinal detachment, cataracts, and macular degeneration [7, 8]. Based on the age of onset, high myopia can be categorized as early-onset high myopia (eoHM), which manifests before the age of 7, and late-onset high myopia (loHM), which develops after school age [9]. EoHM accounts for 0.03–0.2% in China and Singapore populations [10–12]. EoHM can be further divided into non-syndromic eoHM, which presents with simple HM alone, and syndromic eoHM, which presents with other ocular or systemic disorders. Unlike loHM, eoHM is affected mainly by genetic factors, thus providing medical data crucial for the genetic study of HM [13]. EoHM is often accompanied by visual impairment, strabismus, nystagmus, lens abnormalities, fundus disorders, etc. These ocular comorbidities have different impacts on the prognosis of children [14]. EoHM may be a characteristic feature of some systemic or hereditary ocular diseases; [15] however, in some patients, early-stage eoHM presents with simple HM without other eye abnormalities, which can easily lead to missed diagnoses and delay the treatment of fundus and systemic diseases. The use of genetic testing can aid in early screening and diagnosis of eoHM patients [16], but its application is limited because of its high cost. To date, most studies have focused on the genetic basis of eoHM, and the clinical characteristics of this disease have rarely been described. In this study, we collected a large amount of clinical data from eoHM patients, aiming to summarize the clinical characteristics of eoHM and provide clinical data to support standardized diagnosis and treatment in clinical practice. Methods Patients Children with eoHM at the Qingdao Eye Hospital of Shandong First Medical University from July 15, 2024, to September 15, 2024, were prospectively enrolled. Children aged < 7 years with spherical equivalent refraction (SE) ≤ -6.0 D or AL ≥ 26.0 mm in one or both eyes were included in our study. Children aged ≥ 7 years; children who had congenital cataracts, congenital glaucoma, or congenital corneal disease; and children who could not cooperate with the examinations were excluded. The study was registered on the Chinese Clinical Trial Registry (ChiCTR identifier: 2400086082) and performed with approval from the Ethics Committee of Qingdao Eye Hospital of Shandong First Medical University according to the principles of the Declaration of Helsinki. Informed consent was obtained from all the guardians of the children. Ophthalmologic assessment Prior to the study, a detailed medical history, including previous medical history, family history, personal history and systemic abnormalities, was obtained from each subject, and comprehensive eye examinations were performed. All examinations in this study were administered by well-trained ophthalmologists and optometrists. Eye examinations included color vision assessment; slit lamp or hand-held slit lamp microscopy (KJ5S2; Kangjie Medical Co. Ltd., Suzhou, China) to assess the anterior segment; tonometry (Canon TX-20 noncontact tonometer or iCare tonometer TA-03, iCare Finland Oy, Vantaa, Finland) to measure intraocular pressure (IOP); and ultrawide-field scanning laser ophthalmoscopy (ultra-wide-field, OPTOS ® Daytona, England), optical coherence tomography (RTVUE-XR, America) and visual electrophysiological testing (RETI-Port/Scan 21, China) to examine the fundus. AL, keratometry parameters (K), anterior chamber depth (ACD), and lens thickness (LT) were measured with an IOLMaster 700 (Carl Zeiss Meditec AG) before pupil dilation; three measurements were taken for each parameter, and the average value was recorded. A 1% atropine gel (SINQI Pharmaceutical Co., Ltd., Shenyang, China) was applied 2 times per day for five consecutive days, after which the diopter sphere (DS) and diopter cylinder (DC) were measured by a autorefractor keratometer (NIDEK, ARK-1, Japan) under sufficient cycloplegia, and the average of three measurements was recorded. SE was calculated with the following formula: SE = DS + DC/2. Best-corrected visual acuity (BCVA) was measured after pupil dilation using Snellen charts and converted into logarithm of the minimum angle of resolution (LogMAR) units for statistical analysis. Whole-exome sequencing Whole-exome sequencing was conducted on 14 children with eoHM. A total of 5 ml of peripheral venous blood was collected from each participant, and genomic DNA was extracted from the peripheral blood using a QIAamp DNA Mini Kit (Qiagen, Shanghai, China). The DNA was quantified with a Nanodrop 2000 spectrophotometer (Thermo Fisher Scientific, USA). The amplified DNA was captured using a GenCap skeletal system capture kit (MyGenostics Inc., Beijing, China). After sequencing, the raw data were saved in FASTQ format, and bioinformatics analysis was performed. The guardians of all participants in this study provided written informed consent, which explicitly included authorization for the collection of blood samples to be used in genetic research related to eoHM and potential future studies on related ocular conditions. The study protocol, including provisions for the long-term storage and use of biological samples, was reviewed and approved by the Ethics Committee of Qingdao Eye Hospital (Approval No.: Qingyan Lun Shen (Kuai) [2024] No. 37). Following whole-exome sequencing, genomic DNA samples from all participants have been properly stored at -80 °C in the biobank of our research center for future ethically approved studies. Statistical analysis Statistical analysis was performed with SPSS 22.0 software (SPSS, Inc.), and the results are presented as the means ± standard deviations. For the analysis of ocular biometric parameters, data from one randomly selected eye of each participant who met the eoHM diagnostic criteria in both eyes were included in the “binocular eoHM group” for statistical analysis. The Mann‒Whitney U test was employed to ascertain any significant differences in AL, ACD, K, LT, BCVA, or SE between patients with monocular and binocular eoHM. Chi-square analysis was used to compare sex and AL between groups. P < 0.05 was considered to indicate statistical significance. Results Basic clinical characteristics of eoHM A total of 232 children between the ages of 1 and 6 years with early-onset myopia were analyzed in this study, among them, 122 children (52.58%) had eoHM; the mean age of these children was 4.2 ± 1.7 years, 72 children (59.02%) were male, and 50 children (40.98%) were female. Among the children with eoHM, 21 (17.21%) had comorbid systemic diseases, and 65 (53.28%) had comorbid ocular diseases. Among the patients with ocular diseases, 28 (43.08%) had fundus abnormalities (It mainly refers to the characteristic pathological changes associated with systemic or complex ocular disease syndromes, and does not include common axial high myopia manifestations such as tessellated fundus, diffuse chorioretinal atrophy, or peripheral pigmentation), 25 (38.46%) had lens abnormalities, 22 (33.85%) had strabismus, and 6 (9.23%) had nystagmus. A total of 12 children (9.84%) had a history of premature delivery, while 3 children (2.46%) were born with the aid of in vitro fertilization. Twenty-seven children (22.13%) had at least one parent with HM. Thirty-two children (26.23%) had monocular eoHM, and 90 children (73.77%) had binocular eoHM. The BCVA of binocular eoHM patients was greater than that of monocular eoHM patients (P = 0.036). No statistically significant differences in the mean AL, corneal curvature, ACD, LT or SE were detected between monocular and binocular eoHM patients (P = 0.719, P = 0.074, P = 0.150, P = 0.139, P = 0.060, respectively). Only 37 eyes (17.45%) with eoHM had ALs greater than 26 mm. Table 1 shows the clinical characteristics of all the children with eoHM. Table 1Clinical characteristics of children with eoHMParameterTotalmonocular eoHMbinocular eoHM P Children (n/%) 12232(26.23%)90(73.77%)NA Gender (n/%) 0.192 Male7222(30.56%)50(69.44%) Female5010(20%)40(80%) Systemic diseases (n/%) 215(23.81%)16(76.19%)0.782 Ocular diseases (n/%) 6514(21.54%)51(78.46%)0.208 Strabismus227(31.82%)15(68.18%)0.510 Nystagmus61(16.67%)5(83.33%)0.585 Lens abnormality253(12%)22(88%)0.070 Fundus abnormality329(28.13%)23(71.87%)0.157 Personal history (n/%) Premature birth122(16.67%)10(83.33%)0.428 Second or multiple births92(22.22%)7(77.78%)0.776 In vitro fertilization30(0%)3(100%)0.296 Family history274(14.81%)23(85.19%)0.127 Ocular biological parameters BCVA(logMAR)0.65 ± 0.400.79 ± 0.450.62 ± 0.390.036* SE (D)-9.24 ± 3.48-8.05 ± 2.26-9.45 ± 3.620.060 AL (mm)24.94 ± 2.1625.01 ± 1.3424.93 ± 2.270.719 corneal curvature (D)43.17 ± 2.0043.75 ± 1.8343.07 ± 2.020.074 ACD (mm)3.42 ± 0.293.32 ± 0.283.44 ± 0.280.150 LT (mm)3.63 ± 0.343.69 ± 0.293.62 ± 0.330.139 AL features (eyes/%) 0.834 AL ≥ 26 mm37(17.45%)6(18.75%)31(17.22%) AL < 26 mm175(82.55)26(81.25%)149(82.78)SD: standard deviation; BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; ACD: anterior chamber depth; LT: lens thickness; NA: not available. *p value < 0.05. Data of ocular biological parameters was expressed as Mean ± SD Clinical characteristics of children with eoHM SD: standard deviation; BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; ACD: anterior chamber depth; LT: lens thickness; NA: not available. *p value < 0.05. Data of ocular biological parameters was expressed as Mean ± SD Compared to children with eoHM and an AL < 26 mm, those with an AL ≥ 26 mm exhibit longer axial lengths, flatter corneal curvature, deeper anterior chamber depth, and thinner lens thickness (P < 0.001, P = 0.008, P = 0.030, P = 0.028, respectively) (Table 2). Table 2Ocular biological parameters in children with eoHM with different ALParametereoHM with AL ≥ 26 mmeoHM with AL < 26 mm P Children (n/%) 24(19.67%)98(80.33%)NA Ocular biological parameters AL (mm)26.77 ± 1.1124.28 ± 1.08< 0.001 BCVA(logMAR)0.83 ± 0.540.58 ± 0.340.013 SE (D)-10.77 ± 3.47-8.74 ± 3.65< 0.001 corneal curvature (D)42.43 ± 2.0343.40 ± 1.960.008 ACD (mm)3.53 ± 0.393.39 ± 0.240.030 LT (mm)3.52 ± 0.393.63 ± 0.300.028BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; ACD: anterior chamber depth; LT: lens thickness; *p value < 0.05. Data of ocular biological parameters was expressed as Mean ± SD. NA: not available Ocular biological parameters in children with eoHM with different AL BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; ACD: anterior chamber depth; LT: lens thickness; *p value < 0.05. Data of ocular biological parameters was expressed as Mean ± SD. NA: not available No statistically significant differences in the mean AL, corneal curvature, ACD, LT, BCVA or SE were detected between syndromic and non-syndromic eoHM patients (P = 0.129, P = 0.150, P = 0.871, P = 0.312, P = 0.854, P = 0.152, respectively) (Table 3). Table 3Ocular biological parameters in children with syndromic and non-syndromic eoHMParametersyndromic eoHMnon-syndromic eoHM P Children (n/%) 72(59.02%)50(40.98%)NA Ocular biological parameters AL (mm)24.85 ± 1.6325.18 ± 1.260.129 BCVA(logMAR)0.75 ± 0.430.69 ± 0.370.854 SE (D)-10.23 ± 4.03-8.89 ± 2.620.152 corneal curvature (D)43.04 ± 2.1043.77 ± 1.610.150 ACD (mm)3.40 ± 0.263.41 ± 0.280.871 LT (mm)3.68 ± 0.363.60 ± 0.190.312BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; ACD: anterior chamber depth; LT: lens thickness; *p value < 0.05. Data of ocular biological parameters was expressed as Mean ± SD. NA: not available Ocular biological parameters in children with syndromic and non-syndromic eoHM BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; ACD: anterior chamber depth; LT: lens thickness; *p value < 0.05. Data of ocular biological parameters was expressed as Mean ± SD. NA: not available More than half of the children with eoHM had severe comorbidities Among the eoHM patients, 72 (59.02%) had other ocular abnormalities or systemic abnormalities and were classified as having syndromic eoHM, and 50 (40.98%) had non-syndromic eoHM. Among patients with eoHM, the most common systemic comorbidities were Marfan syndrome (15/122, 12.30%) and Stickler syndrome (2/122, 1.64%). The most common ocular comorbidities were lens dislocation (23/122, 18.85%) and inherited retinal degeneration (IRD) (14/122, 11.48%) (Fig. 1A and B). Among IRD patients, retinal pigmentosa (RP) and retinal degeneration (RD) were the most common manifestations. The classification of eoHM patients with IRD is shown in Fig. 1C. In children with lens dislocation, the mean corneal curvature was 41.43 ± 1.55 D, the mean AL was 23.58 ± 1.09 mm, the mean ACD was 3.38 ± 0.21 mm, and the mean LT was 3.99 ± 0.51 mm. The systemic or ocular comorbidities of eoHM patients. (A) The classification of eoHM patients with systemic comorbidities. (B) The classification of eoHM patients with ocular comorbidities. (C) The classification of eoHM patients with IRD. EoHM: Early-onset high myopia; MCLS: Mucocutaneous lymph node syndrome; IRD: Inherited retinal degeneration; ROP: Retinopathy of prematurity; RD: Retinal degeneration; CD = Choroidal defect; MRNF = Myelinated retinal nerve fiber; RP: Retinal pigmentosa; FEVR: Familial exudative vitreoretinopathy; ADCSNB: Autosomal dominant congenital stationary night blindness. IRD: Inherited retinal diseases are a group of genetic ocular disorders characterized by degenerative changes in the retinal photoreceptors and retinal pigment epithelium. They primarily include retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), Stargardt disease (STGD), choroideremia (CHM), Leber hereditary optic neuropathy (LHON), achromatopsia (ACHM), and X-linked retinoschisis, among others [17]. RD: Retinal degeneration in this study is explicitly defined as characteristic pathological alterations of the retina associated with systemic or complex ocular syndromes (e.g., Stickler syndrome), primarily encompassing typical manifestations such as peripheral retinal lattice degeneration. This definition specifically excludes nonspecific signs attributable solely to axial elongation, including but not limited to diffuse chorioretinal atrophy and white without pressure Composition of ocular comorbidities differed between binocular and monocular eoHM Compared with the binocular group, the monocular group included more patients with pure HM and no other comorbidities. The composition of comorbidities differed between the two groups. Lens dislocation (20/90, 22.22%) and IRD (11/90, 12.22%) were the most common ocular comorbidities in the binocular group, whereas myelinated retinal nerve fibers (MRNF) (4/32, 12.50%), lens dislocation (3/32, 9.38%) and IRD (3/32, 9.38%) were the most common comorbidities in the monocular group. In summary, lens and retinal abnormalities are the most common comorbidities in both unilateral and bilateral eoHM patients. The ocular comorbidities of monocular and binocular eoHM patients are shown in Fig. 2. Ocular comorbidities of binocular and monocular eoHM patients. IRD: Inherited retinal degeneration; ROP: Retinopathy of prematurity ; RD: Retinal detachment; CD: Choroidal defect; MRNF: Myelinated retinal nerve fiber; No: No apparent comorbidity; eoHM: Early-onset high myopia Most eoHM patients have retina-related gene mutations Whole-exome sequencing was performed in 14 children with eoHM (9 males and 5 females). The most of gene variants (13/14, 92.86%) interfere with the physiological mechanisms of the retina. The most common gene mutation types were missense mutations (28.57%) and frameshift mutations (28.57%). These genetic variants are associated with the risk of three retinal diseases: RP (2 families), cone‒rod dystrophy (CORD) (2 families), and autosomal dominant congenital stationary night blindness (ADCSNB) (2 families). The clinical manifestations and genetic test results of these 14 patients are shown in Tables 4 and 5. Table 4Clinical characteristics of 14 eoHM patients who underwent genetic testnumberADHMSexBCVASE (D)AL (mm)Related diseasesODOSODOSODOS16F0.40.3-21-1224.0524.87lens dislocation24F0.50.4-12.25-12.525.6225.47X-linked retinoschisis36M0.50.5-6-3.7523.9123.36FEVR45M0.050.05-7.25-7.524.5324.67RP52M---6-724.8325.02retinal degeneration64M0.70.8-7-6.7524.9424.69CORD72M---8.5-8.7524.8924.87ADCSNB86M0.30.5-7-425.2124.12RP91M---4-624.0025.01pathological myopia103M---6-5.2524.4924.46Aland Island eye disease112F---7.25-5.523.6322.61retinal dystrophy122M---6.75+ 1.7523.6422.41pathological myopia133F---7.25-7.524.2824.19CORD143F---10-5.7524.2622.77ADCSNBADHM: age at diagnosis of HM; BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; FEVR: Familial Exudative Vitreoretinopathy; RP: retinitis pigmentosa; CORD: cone-rod dystrophy; ADCSNB: autosomal dominant congenital stationary night blindness; eoHM: Early-onset high myopia; OD: Oculus Dexter; OS: Oculus Sinister. The symbol “-” is used when a patient cannot undergo standard visual acuity testing because they are too young or have cognitive issues Clinical characteristics of 14 eoHM patients who underwent genetic test ADHM: age at diagnosis of HM; BCVA: best-corrected visual acuity; AL: axial length; SE: spherical equivalent; FEVR: Familial Exudative Vitreoretinopathy; RP: retinitis pigmentosa; CORD: cone-rod dystrophy; ADCSNB: autosomal dominant congenital stationary night blindness; eoHM: Early-onset high myopia; OD: Oculus Dexter; OS: Oculus Sinister. The symbol “-” is used when a patient cannot undergo standard visual acuity testing because they are too young or have cognitive issues Table 5Genetic test results of 14 EoHM childrennumberChrom-osomeMutationsProtein ChangesGeneASACMG Criteria AppliedAC1chr 15c.1904 A > Gp.Tyr635CysFBN1hetPM1 + PP3 + PS4 + PM2LP2chr Xc.2426_2427dp.Glu809GlyfsTer25RPGRhetPVS1 + PS2 + PS4 + PM2P3chr 11c.317G > Tp.C106FFZD4hetPM1 + PM2 + PM5 + PP3P4chr 4c.1645_1648delp.Lys549GlnfsTer3PRO M1hetPVS1 + PM3 + PM2Pc.2321delp.Ala774ValfsTer2hetPVS1 + PM2LP5chr 3c.54delp.Pro19ArgfsTer185P3H2hetPVS1 + PM2LPc.1918 C > Tp.Arg640CyshetPM2 + PM3 + PP3U6chr 14c.437G > Ap.Gly146GluTTLL5hetPM2Uc.1154 C > Gp.Ala385GlyhetPM2U7chr 5c.1163G > Cp.Arg388ProGRM6hetPM2Uc.94_162delp.Ser32_Gly54delhetPM2U8chr 8c.4955G > Tp.Arg1652LeuRP1hetPM3 + PM2U9chr 4c.882 C > Gp.Tyr294TerLRPA P1hetPVS1 + PM2LPc.205–25 A > ChetPM2U10chr Xc.2000T > Cp.Phe667SerCACNA1FhemPM2Uc.935 A > Gp.Asn312SerhemPM2U11chr4c.3106G > Tp.Asp1036TyrALPK1hetBP4U12chr22c.66_69delp.Pro23GlyfsTer10SCO2hetPVS1 + PM2LP13chr10c.251T > Cp.L84PPDE6ChetPS2 + PM2 + PM3 + PP3LPchr10c.304 C > Tp.R102WPDE6ChetPM2 + PP3U14chr 2c.694 A > Tp.N232YSAGhetPM1 + PM2UAS: allele status; AC, ACMG-Guideline Class; P: pathogenic; LP: ikely pathogenic; U: uncertain significance; het: heterozygote; hem: hemizygote; eoHM: Early-onset high myopia Genetic test results of 14 EoHM children p.Glu809Gly fsTer25 p.Lys549Glnf sTer3 p.Ala774Valf sTer2 p.Pro19Argfs Ter185 p.Ser32_Gly 54del AS: allele status; AC, ACMG-Guideline Class; P: pathogenic; LP: ikely pathogenic; U: uncertain significance; het: heterozygote; hem: hemizygote; eoHM: Early-onset high myopia Discussion Because the incidence rate of eoHM is low and patients are young, it is difficult to collect a substantial amount of clinical data. To date, most studies on eoHM have focused on genetic research. In this study, we collected a large amount of clinical data from Chinese children with early-onset myopia and eoHM to summarize the clinical characteristics of eoHM and provide a theoretical basis for a standardized clinical diagnosis and treatment. The onset age of eoHM is before school age; therefore, the condition is determined more by genetic factors than by environmental factors [9]. Children with eoHM often present with ocular abnormalities such as strabismus, nystagmus, glaucoma, lens dislocation, retinopathy of prematurity (ROP), retinal detachment, and IRD [18, 19]. In our study, the children with eoHM had a mean SE of -9.24 ± 3.48 D and a mean AL of 24.94 ± 2.16 mm, and only 17.45% of eoHM eyes had an AL greater than 26 mm. We also found that children with an AL ≥ 26 mm exhibited longer axial lengths, flatter corneal curvature, deeper anterior chamber depth, and thinner lens thickness in comparison to those with an AL < 26 mm. Compared to children with eoHM and an AL of less than 26 mm, those with an AL ≥ 26 mm exhibit systematic and patterned changes in the entire ocular structure. During ocular development, what appears to be a “compensatory mechanism” seems to be at play: when the AL becomes excessively elongated, the cornea flattens relatively and the lens may become thinner, thereby partially offsetting the increase in myopia caused by axial elongation. Children with eoHM presented an increase in SE rather than an increase in AL. This trend is different from that observed in patients with loHM, in whom the degree of myopia is proportional to the AL and corneal curvature. We hypothesized that eoHM has different ocular biometric parameters than loHM because of its distinct pathogenesis and clinical manifestations. Biometric assessment is an important tool in monitoring the eye development of children with eoHM. Other examinations include anterior and posterior segment detection and genetic testing, which typically require the involvement of pediatricians and clinical geneticists. The data from this study indicate that among children with eoHM complicated by ocular diseases, fundus abnormalities (43.08%) and lens abnormalities (38.46%) are the most prevalent. This distribution pattern suggests that the etiology of eoHM is closely associated with the homeostasis of the posterior ocular segment structure and the function of the lens zonule. Fundus abnormalities may stem from impaired synthesis and remodeling of scleral collagen, leading to insufficient resistance to intraocular pressure, while lens abnormalities are often caused by developmental weakness or rupture of the zonular fibers. At the genetic level, mutations in connective tissue-related genes such as FBN1, COL2A1, and COL18A1 can individually cause conditions like Marfan syndrome and Stickler syndrome, or collectively contribute to congenital ocular fragility, manifesting as eoHM and its associated fundus or lens pathologies. Specifically, lens dislocation, the most common lens abnormality, is frequently associated with systemic disorders such as Marfan syndrome. This highlights the necessity for systemic evaluation, particularly cardiovascular assessment and genetic testing for genes like FBN1, in eoHM children with lens dislocation. On the other hand, IRDs, as common comorbidities of eoHM, hold critical clinical significance. Some of these conditions may initially present only as progressive myopia without typical fundus changes, leading to misdiagnosis as “isolated” high myopia and potentially delaying genetic counseling and prognosis assessment. Therefore, this study repositions eoHM from an isolated refractive issue to an important clinical marker for multiple potential severe disorders. We recommend establishing a standardized evaluation protocol for eoHM children: in addition to routine refraction, mandatory dilated fundus examination and lens assessment should be performed. For suspected cases, early implementation of axial length monitoring, electroretinography (ERG), and genetic testing is advised to achieve early differentiation, precise intervention, and improved prognosis management. Our results revealed that more than half of the children with eoHM presented with syndromic eoHM, and the most common comorbidity of eoHM was lens dislocation (18.85%), followed by IRD (11.48%). EoHM may be a specific indicator of ocular or systemic abnormalities. Marr et al. reported that only 8% of eoHM children presented with simple HM, whereas 38% of children presented with accompanying ocular conditions [20], which is consistent with our finding that more than half of eoHM children exhibited ocular or systemic abnormalities. Another study revealed that simple HM, familial exudative vitreoretinopathy (FEVR) and Stickler syndrome were the most common causes of eoHM [21]. This result differs from our finding that eoHM is most commonly associated with lens dislocation and IRD; this difference may be due to the difference in the number and type of children included in the two studies. Lens dislocation was the most frequent comorbidity detected in this study. There were 23 (18.85%) eoHM patients with lens dislocation, 73.91% of which suffered from Marfan syndrome. Marfan syndrome is caused by mutations in the FBN1 gene; these patients usually have lens dislocation, eoHM, possibly flat corneas, disproportionately elongated ALs and irregular astigmatism [22, 23]. These characteristics are consistent with our findings; in our study, the mean corneal curvature of children with lens dislocation was 41.43 ± 1.55 D, and the mean AL was 23.58 ± 1.09 mm. In this group of children, the AL of the eyes is relatively short, and the corneal curvature tends to be flat, yet their refractive status presents as high myopia. This suggests that there may be significant abnormalities in the shape or position of the lens, which serve as the primary cause of eoHM. Therefore, if a mismatch between ocular biological parameters and refractive status is observed clinically, a detailed evaluation of the lens under cycloplegia must be conducted to promptly identify any abnormalities in its shape or position. IRD, the second most common comorbidity of eoHM in this study, includes RP, FEVR, RD, ADCSNB, retinal dystrophy, X-linked retinoschisis and congenital macular dysplasia. In the initial stages, these diseases present as uncomplicated HM without other morphological abnormalities that can be identified through routine eye examinations. Consequently, these patients are frequently misdiagnosed and treated for simple HM. For instance, in the early stages of disease, children with retinal pigmentosa or certain retinal dystrophies may only report decreased vision, while morphological changes in the fundus remain inconspicuous. FEVR is characterized by peripheral retinal avascular zones and vascular traction, yet it is easily missed without fully dilated fundus examination. Myopia in FEVR is often bilateral and asymmetric. Children with ADCSNB, in addition to high myopia, often experience night blindness from an early age. However, due to their young age, they may be unable to articulate this symptom accurately. While the fundus morphology is mostly normal, ERG may reveal a characteristic “negative waveform” or severely impaired rod responses, and genetic testing can aid in diagnosis. Furthermore, the foveal schisis in X-linked retinoschisis is often subtle and easily overlooked during routine examinations. The significant disparity between the presentation of “high myopia” and the potential for severe prognosis poses a critical challenge in the clinical management of eoHM. Therefore, for such patients, clinicians must not settle for refractive correction alone. Instead, functional examinations such as electroretinography should be integrated to thoroughly investigate potential retinal functional abnormalities. ROP is another common comorbidity of eoHM, and 12 (9.84%) children had a history of premature birth in our study, which is consistent with the theory that prematurity is the most prominent environmental factor in eoHM [24]. In patients with ROP, eoHM is not predominantly caused by axial myopia but mainly by changes in the cornea, ACD, and crystalline lens [25, 26], which may also explain the characteristics of the ocular biological parameters in our study. In addition, in the complex treatment of ROP, the number of laser treatments is an independent risk factor for eoHM, and early refractive examination should be considered for infants who have received laser treatment [27]. In our study, compared with the binocular group, the monocular group included more patients with pure HM and no other comorbidities. The onset of binocular eoHM often involves a greater proportion of genetic factors and a more severe degree of mutation, which may explain the more frequent occurrence of binocular eoHM with other comorbidities. The composition of comorbidities differed between binocular eoHM and monocular eoHM. MRNF was the most common comorbidity in the monocular group. MRNF can cause local visual deprivation, which is the reason why the condition is usually associated with an increased degree of axial myopia [28, 29]. Patients with lens dislocation or IRD in the monocular group also had varying degrees of myopia in the contralateral eye, but the degree of myopia was <-6.0 D. This finding can explain the greater proportion of lens dislocation and IRD in the monocular group. In summary, lens and retinal abnormalities are the most common comorbidities in both unilateral and bilateral eoHM patients. EoHM is an early-occurring characteristic of IRD caused by genetic mutations, and the application of genetic testing technology can aid in the early screening and diagnosis of these patients; [30, 31] therefore, in addition to detailed eye examinations, genetic diagnosis is also highly valuable for the diagnosis of eoHM. Multiple research teams at home and abroad have conducted genetic studies on eoHM. ARR3 is a causative gene of eoHM located on the X chromosome but known for its female-limited nature [32]. RBP3-related disease should be considered in children with eoHM and retinal dystrophy [33]. Zi et al. were the first to report five novel hemizygous variants in the OPN1LW, RP2, GPR143, FRMD7 and HMGB3 genes that are associated with eoHM [34]. Another study revealed mutations in the CCDC111, SLC39A5, P4HA2, CPSF1 and GRM6 genes associated with eoHM [35]. One study provided more evidence that mutations in ARR3, SLC39A5 and NDUFAF7 are causative eoHM. A total of 14 children with eoHM in this study underwent genetic testing, and all of them were found to carry ocular inherited disease-related gene variants. Notably, the results of genetic testing of a portion of eoHM patients who present only simple HM suggested other ocular-related mutations and possible diseases, indicating the crucial role of genetic testing in the early diagnosis of eoHM. Several limitations should be considered in this study. Because of the low incidence of eoHM, it was difficult to collect a large number of cases. Most genetic testing results revealed variations related to retinal diseases, which are not consistent with the most common clinical comorbidity of lens dislocation. A possible explanation is that the genetic testing results in our study are limited. All cases were recruited from a single tertiary referral center over a relatively short enrollment period, which may introduce referral bias. This could lead to a reported comorbidity rate that is higher than the actual prevalence in the general population and may limit the generalizability of the findings to broader populations. In summary, the findings of this study confirm that eoHM often exists as part of a complex syndrome, providing a crucial basis for early clinical diagnosis and systemic intervention. Therefore, it is recommended to conduct comprehensive ophthalmic examinations and genetic evaluations for children with eoHM to promptly identify and manage associated ocular and systemic abnormalities. Acknowledgements No. Abbreviations Early-onset High Myopia Best-Corrected Visual Acuity Spherical Equivalent Axial Length Inherited Retinal Degeneration High Myopia Spherical Diopters Late-onset High Myopia Diopter Sphere Diopter Cylinder Anterior Chamber Depth Lens Thickness Retinal Pigmentosa Retinal Degeneration Mucocutaneous Lymph Node Syndrome Retinopathy of Prematurity Choroidal Defect Myelinated Retinal Nerve Fiber Familial Exudative VitreoRetinopathy Autosomal Dominant Congenital Stationary Night Blindness Age at Diagnosis of HM Cone-rod Dystrophy Oculus Dexter Oculus Sinister Allele Status Pathogenic Lkely Pathogenic Uncertain significance Heterozygote Hemizygote Author contributions DYC was responsible for writing the protocol and report, conducting the search, and analysing data, interpreting results. XFJ, ZJ, JMM, WT contributed to data extraction and provided feedback on the report. WXM contributed to the design of the review protocol, writing the report and analysing data and interpreting results. Funding Supported by the Shandong Provincial Natural Science Foundation of China (ZR202211260284). Data availability The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The study was registered on the Chinese Clinical Trial Registry (ChiCTR identifier: 2400086082) and performed with approval from the Ethics Committee of Qingdao Eye Hospital of Shandong First Medical University according to the principles of the Declaration of Helsinki. Informed consent was obtained from all the guardians of the children. Consent for publication Not applicable. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Data Availability Statement The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.